Innovative TechnologyA multi-billion-dollar opportunity exists with its cloud platform to manage hospital ECGs and provide AI disease detection.
Product DevelopmentHeartSciences signed its first MyoVista Insights Platform customer, Westcliffe Health Innovations, in the UK.
Regulatory ApprovalThe company expects to submit its MyoVista device for FDA approval, which could lead to significant advancements in their product offerings.